logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

David E Nichols

This inventor holds 29 USPTO granted patents and 25 published patent applications and 1 EPO patent, primarily in Psychedelic Compounds. Top assignees: Compass Pathfinder Limited, Eleusis Therapeutics US, Inc., 2A Biosciences, Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David E Nichols. Retrieved from https://idiyas.com/inventor/david-e-nichols

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 

% Patents Active = 79.3

 

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 323(Granted Patents)


Location History:

  • San Antonio, TX (US) (2003)
  • Chapel Hill, NC (US) (2019 - 2024)

Company Filing History:

goldMedal22 out of 25 
 
Compass Pathfinder Limited
 patents
silverMedal3 out of 4 
 
Eleusis Therapeutics US, Inc.
 patents
bronzeMedal1 out of 1 
 
2A Biosciences, Inc.
 patent
4. 1 out of 1 
 
Compass Pathways Limited
 patent
5. 1 out of 839 
 
Louisiana State University and Agricultural & Mechanical College
 patents
where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Psilocybin
Phenethylamines
Anxiety Disorders
Neurocognitive Disorders
Chronic Pain
Inflammatory Disorders
Pharmaceutically Acceptable Salts
Polymorphic Forms
Formulations
Headache Disorders
Eating Disorders
Fishing Lure
29 patents (USPTO):Explore Patents
1. 12751960 - Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin (2026-10-06),
2. 12692221 - 5-methoxymethyl and 5-hydroxymethyl phenethylamines (2026-07-28),
3. 12668605 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use (2026-06-30),
4. 12662498 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use (2026-06-23),
5. 12643917 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use (2026-06-02),
6. 12611418 - Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin (2026-04-28),
7. 12545642 - Pharmaceutically acceptable salts of psilocin and uses thereof (2026-02-10),
8. 12459965 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use (2025-11-04),
9. 12447164 - Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin (2025-10-21),
10. 12433904 - Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin (2025-10-07),
11. 12398093 - Compounds and methods for treating inflammatory disorders (2025-08-26),
12. 12377112 - Methods of treating neurocognitive disorders, chronic pain and reducing inflammation (2025-08-05),
13. 12312375 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use (2025-05-27),
14. 11939346 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use (2024-03-26),
15. 11865126 - Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin (2024-01-09),

Title: The Innovative Mind of David E. Nichols

Introduction: David E. Nichols, a renowned inventor hailing from Chapel Hill, NC, is a distinguished figure in the field of pharmaceuticals and medicinal chemistry.

Latest Patents: David E. Nichols holds several groundbreaking patents in the development of novel psychoactive compounds and medications that have revolutionized the treatment of various mental health disorders.

Career Highlights: With a career spanning several decades, David E. Nichols has made significant contributions to the scientific community through his research and inventions in the realm of psychopharmacology. His work has led to the development of innovative treatments for conditions such as depression, anxiety, and addiction.

Collaborations: Throughout his career, David E. Nichols has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further the advancement of psychopharmacology. His collaborative efforts have resulted in the creation of cutting-edge medications that have had a profound impact on patient care.

Conclusion: David E. Nichols' dedication to innovation and his relentless pursuit of scientific excellence have solidified his reputation as a pioneering inventor in the field of pharmaceuticals. His contributions continue to shape the landscape of modern medicine, offering hope and healing to countless individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…